HOME >> BIOLOGY >> NEWS
Researchers identify protein promoting vascular tumor growth

COLUMBUS, Ohio Researchers have discovered a new mechanism responsible for the growth of blood vessel tumors that can cause facial deformities in infants and young children, paving the way for an antibody-based treatment to remove cells that fuel the tumors' growth.

Blood vessel tumors require macrophages, a type of white blood cells, to develop. In studying these cells' role in tumor development, Ohio State University medical researchers determined that a protein called MCP-1 "recruits" macrophages to the vascular tumor site.

This means that therapies to eliminate the MCP-1 protein could be a key to healing or preventing the tumors and possibly others in which MCP-1 is expressed.

The results are published in the October issue of the American Journal of Physiology (Cell).

Blood vessel tumors affect up to 3 percent of all children, typically resulting in a prominent red mass on the head and neck. Up to one in four patients with hemangioendotheliomas, or HEs, the type of tumor used in these studies, die of anemia associated with the tumors.

The findings present the first evidence that MCP-1 and macrophages are needed for these tumors to grow, and the first evidence that anti-MCP-1 therapy prevents vascular tumor development in animals with intact immune systems, said Gayle Gordillo, lead author of the study, assistant professor of plastic surgery and an investigator in the Davis Heart and Lung Research Institute at Ohio State University Medical Center.

When MCP-1 recruits macrophages to the tumor site, it stimulates new blood vessel development, or angiogenesis, in endothelial cells that make up the lining of blood vessels. That proliferation can cause the tumors to grow because new vessels develop and allow blood to collect in the lesion. Gordillo, in partnership with Heart and Lung Research Institute investigators Chandan Sen and Sashwati Roy, determined MCP-1's role in recruiting macrophages by
'"/>

Contact: Emily Caldwell
caldwell.151@osu.edu
614-293-3737
Ohio State University
29-Sep-2004


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers devise potent new tools to curb ivory poaching
4. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
5. Researchers ID chlorophyll-regulating gene
6. Researchers develop fast track way to discover how cells are regulated
7. Researchers identify distinctive signature for metastatic prostate cancer
8. Researchers report new gene test for isolated cleft lip and palate
9. Researchers discover why mutant gene causes colon cancer
10. Researchers identify the genomes controlling elements
11. Researchers improve detection of diverse anthrax strains

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2020)... ... 2020 , ... ImStem Biotechnology, Inc. (Farmington CT), a biopharmaceutical ... cells (hES-MSC), through a proprietary method using a trophoblast intermediate stage (hence also ... today announced that the U.S. Food and Drug Administration (FDA) has lifted the ...
(Date:3/19/2020)... ... ... The former Jason "Furious" Styles of "Boyz n the Hood" (1991), Laurence ... TV program highlights a large variety of subjects that have an impact on a ... dive into the world of applied academics. The episode will cover education in biomechanical ...
(Date:3/13/2020)... BROOKLINE, Mass. (PRWEB) , ... March 13, 2020 ... ... suggest that the new outbreak of coronavirus can cause conjunctivitis and possibly be ... covering the eye. , Contact lens wearers should take special precautions to ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 20, 2020 ... ... exquisite capability to perform complex, efficient and elegant chemistry. Humans have been ... to our own goals. , Through rapidly evolving technologies and strategies for ...
(Date:2/21/2020)... ... February 21, 2020 , ... Pharmaceutical manufacturers are under increasing ... adapt to new approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing ... and therapies. But with an industry with the world’s tightest regulations and complex ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... process solutions for the life sciences industry, today announced the opening of a ... Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office ...
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro Technologies, Inc. ... today announced that the City of Fort Worth has partnered with Synagro of ... in April of 2020, Synagro will assume operation of the city’s current biosolids ...
Breaking Biology Technology:
Cached News: